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Chromatin regulatory complexes are well known regulators of stem cell fate; however, the mechanisms
regulating their activity are not well understood. In this issue of Cell Stem Cell, Bao et al. (2013) show that
ACTL6a inhibits targeting of the SWI/SNF complex to differentiation genes, thereby preserving the epidermal
progenitor state.Overwhelming evidence collected over
the last decade has pointed to a critical
role for chromatin regulators, such as
Polycomb Repressive Complex 1/2,
Nucleosome Remodeling and Deacety-
laseComplex, and the SWI/SNF complex,
in controlling stem cell fate (Hu andWade,
2012; Lessard and Crabtree, 2010;
Surface et al., 2010; Wu et al., 2009). In
general, chromatin regulators are thought
to alter chromatin structure either by
modulating DNA, histone modifications,
or both, or by remodeling nucleosomes,
which changes the accessibility of gene
regulatory elements to the transcriptional
machinery and leads to either gene acti-
vation or silencing. Most chromatin regu-
lators are multisubunit complexes that
consist of a few proteins possessing
enzymatic activities and a large number
of regulatory subunits that are thought to
have a modulatory function in regulating
affinity to DNA sites, stabilizing the
complex, and enhancing or inhibiting the
complex’s activity (Hu and Wade, 2012;
Surface et al., 2010; Wu et al., 2009).
Thus far, the majority of insights into their
function have been gained from loss-of-
function studies where enzymatic com-
ponents of chromatin regulators were
ablated, revealing phenotypes ranging
from loss of stem cell self-renewal and
aberrant differentiation to apoptosis
(Hu and Wade, 2012; Surface et al.,
2010; Wu et al., 2009). However, despite
the proposed role for the nonenzymatic
regulatory subunits of chromatin com-
plexes in performing a fine-tuning func-
tion, our knowledge of the relative im-
portance of their activities in controlling
stem cell function is very limited. In work
by Bao et al. (2013) published in thisissue of Cell Stem Cell, the authors
address this issue by uncovering the
role for the SWI/SNF interacting protein
Actin-like 6a (ACTL6a) in promoting the
maintenance of epidermal progenitor cell
state.
The SWI/SNF complex is a chromatin
remodeling complex that functions to
destabilize histone-DNA interactions, re-
sulting in an open chromatin state and
leading to transcriptional activation (Hu
and Wade, 2012; Wu et al., 2009). It
consists of the catalytic ATPase subunits
Brg1 and Brm as well as 11 regulatory
subunits. Interestingly, these subunits
can be encoded by at least 20 different
genes, resulting in 288 possible com-
binations (Wu et al., 2009). It has been
speculated that different combinatorial
assemblies of the SWI/SNF complexes
have different DNA target affinities and
functions (Wu et al., 2009). Studies of
neuronal stem cells have confirmed that
the composition of the SWI/SNF complex
changes between stem cells and postmi-
totic neurons, and, importantly, showed
that this switch is required for proper
differentiation (Lessard et al., 2007). The
SWI/SNF complex has also been shown
to be essential for proper execution
of the differentiation program in the
epidermis, where it regulates the contin-
uous transition of epidermal progenitor
cells to the stratified layers (Indra et al.,
2005). Previous studies showed that loss
of expression of Brg1 and Brm leads
to aberrant expression of differentiation
genes and results in defective formation
of the differentiated layers (Indra et al.,
2005). However, how SWI/SNF activity is
modulated during epidermal differentia-
tion was unknown up to this point, andCell Stem Cell 12has been addressed in the current study
by Bao et al. (2013).
Khavari and colleagues focused on
ACTL6a because it is expressed in
epidermal progenitor cells and is downre-
gulated during differentiation. To dis-
sect the role of ACTL6a in control of the
epidermis, loss-of-function studies were
performed where ACTL6a was condition-
ally ablated in embryonic and adult mouse
skin. These studies revealed thinning and
erosion of the epidermis, and showed that
the phenotype was due to loss of pro-
liferation of the progenitor cells and
premature expression of differentiation
markers. The authors expanded this anal-
ysis to human cells and showed that
RNAi-induced ablation of ACTL6a led to
proliferation arrest and induced differ-
entiation, while ACTL6a overexpression
suppressed the epidermal differentiation
program, indicating that the role of
ACTL6a in the maintenance of epidermal
progenitor state is conserved between
mammalian species.
To gain insight into the mechanism of
ACTL6a function in controlling epidermal
differentiation, the authors performed bio-
informatic analysis and found that the
majority of the ACTL6a-regulated genes
contained a DNA binding site for KLF4,
the Kruppel-like factor 4 transcription
factor, a prominent activator of differenti-
ation in the epidermis (Segre et al., 1999).
Consistent with this analysis, loss of
ACTL6a expression from both human
organotypic cultures and mouse skin re-
sulted in the upregulation of KLF4 and its
target genes, and further genetic epistasis
analysis confirmed that KLF4 is indeed
required for the expression of differentia-
tion genes upon loss of ACTL6a in vitro., February 7, 2013 ª2013 Elsevier Inc. 141
Cell Stem Cell
PreviewsACLT6a has been described to be part
of several epigenetic regulator complexes
(Wu et al., 2009). Loss-of-function anal-
ysis of the key components of ACTL6a-
containing complexes, however, revealed
that reduced proliferation and precocious
expression of differentiation genes in epi-
dermal progenitors was unique to loss of
BAF250a/ARID1A, the largest SWI/SNF
subunit. Biochemical purifications con-
firmed interaction between ACTL6A
and the SWI/SNF complex and genetic
studies showed that a mutant form of
ACTL6a that cannot bind the catalytic
Brg1 subunit of SWI/SNF failed to reverse
the differentiation phenotype observed
upon loss of ACTL6a in vitro. These data
thus clearly indicate that ACTL6a works
together with SWI/SNF to control the
epidermal progenitor cell state.
Removal of Brg1 and Brm from the
epidermis results in differentiation defects
(Indra et al., 2005), while removal of
ACTL6a leads to precocious differentia-
tion (Bao et al., 2013), suggesting that
ACTL6a functions to inhibit SWI/SNF
activity. This model was confirmed by
the observation that SWI/SNF binding to
the target differentiation genes is in-
creased in differentiated keratinocytes as
well as in keratinocytes where ACTL6a
had been removed (Bao et al., 2013).
These data indicate that the downregula-
tion of ACTL6a in keratinocytes is critical
to allow SWI/SNF to bind and promote
expression of differentiation genes, in-
cluding KLF4, to execute proper epi-
dermal differentiation.
Importantly, ACTL6a appears to main-
tain epidermal progenitor state by pre-
venting premature exit from the cell cycle
and downregulating the expression of
differentiation genes (Bao et al., 2013).
Recent studies showed that ACTL6a/
BAF53a activity is required for progenitor142 Cell Stem Cell 12, February 7, 2013 ª201proliferation and maintenance in hemato-
poietic and neuronal stem cells (Krasteva
et al., 2012; Lessard et al., 2007). It is
thus tempting to speculate that ACTL6a
might be a general regulator of stem cell
maintenance.
In the future it will be important
to understand the different mechanistic
roles that the actin-like proteins are
carrying out in the SWI/SNF complexes
and how these roles are modulated in
specific cell types. How does ACTL6a
inhibit DNA targeting of the SWI/SNF
complex? Also, how is ACTL6a downre-
gulated upon differentiation? In neu-
ronal stem cells, microRNAs are required
for repression of ACTL6a/BAF53a (Yoo
et al., 2009); however, the mechanism of
ACTL6a downregulation in the epidermis
remains to be determined. Studies in
neuronal stem cells and embryonic stem
cells showed that there are changes in
the composition of the SWI/SNF complex
between stem cell and committed proge-
nies (reviewed in Lessard and Crabtree,
2010). While Bao et al. (2013) clearly
showed that ACTL6a and BAF250a are
required for epidermal progenitor cell
maintenance, it will be important to inves-
tigate SWI/SNF composition in epidermal
differentiated cells and to uncover
subunits that are required for differentia-
tion. It will also be important to define
how the different combinations of SWI/
SNF subunits confer functional diversity
and uncover other cell-specific factors
that may be implicated in the recruitment
of this complex to tissue-specific target
genes.
Finally, understanding this complexity
will be critical for uncovering the role that
the SWI/SNF complex plays in cancer.
Loss of expression of different subunits
of SWI/SNF, such as Brg1, Brm, BAF47,
BAF57, BAF45, and BAF155 (Wu et al.,3 Elsevier Inc.2009), has been reported in human tumor
cell lines. Due to the identified role of SWI/
SNF in promoting progenitor/stem cell
proliferation in the epidermis, brain, and
blood, it is plausible to hypothesize
that changes in expression of SWI/SNF
components might also provide prolifera-
tive advantages to other cell types,
contributing to tumorigenesis (Wu et al.,
2009). This paper provides an interesting
opening into studying the functions of
different combinatorial assemblies, as
well as the precise mechanisms of cell-
specific recruitment to target genes, and
we look forward to future research into
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